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Eight known secondary metabolites were isolated from the methanolic extract of the whole plant of Astragalus lycius Boiss. They were identified as 5,5’-
dihydroxy-3’-methoxy-isoflavone-7-O--D-glucoside (1), genistin (2), sissotrin (3), 5,4’-dimethoxy-isoflavone-7-O--D-glucopyranoside (4), (7S,8R)-5-
methoxydehydrodiconiferyl alcohol-4-O--D-glucopyranoside (5), 4-O-lariciresinol-glucoside (6), 2-phenylethyl--D-glucopyranoside (7) and -sitosterol-3-
O-β-D-glucopyranoside (8) by spectroscopic methods including 1H- and 13C-NMR and HR-MS experiments, and by comparison with literature values. 
Compounds 1-7 are reported for the first time from Astragalus taxa. All of the compounds were tested for their cytotoxic activities against a number of cancer 
cell lines. Among them, only 6 exhibited significant activity against human colon carcinoma (HT-29) at 2.69 M concentration. 
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 Leguminosae is a family of flowering plants comprising about 269 
genera and 5100 species [1]. Astragalus L. is represented by 62 
sections, 447 species in the Flora of Turkey, 50% of which are 
endemic [1, 2]. In Turkish folk medicine, while the aqueous extracts 
of some Astragalus species are used to treat leukemia besides 
wound healing properties [3a,b] in the East part of Anatolia, gums 
of some Astragalus species used to cure sore throat, stomach aches 
and some cancers [4]. Decoctions prepared from the roots are also 
used in the treatment of diabetes and jaundice [5]. It has been 
reported that a series of triterpene saponins both oleanane and 
cycloartane types together with flavonoids were isolated in previous 
studies performed on Astragalus species [6a,b,c,d]. 
 
As part of our studies on the chemical constituents of Turkish 
Astragalus species, we carried out a study on an endemic species, 
namely A. lycius Boiss. (Leguminosae). This is the first 
phytochemical study reported from the section Onobrychium, 
describing isolation and structure determination of eight known 
secondary metabolites from the methanolic extract of the whole 
plant of A. lycius. The isolates were identified by 1H- and 13C-NMR 
as well as ESI-MS and HR-MS analyses. Seven of the isolated 
compounds are reported for the first time from Astragalus taxa. 
 
The methanolic extract of the air-dried and powdered plant material 
of A. lycius was separated by a combination of VLC (vacuum liquid 
chromatography) on stationary and reverse phases, CC (column 
chromatography) on silica gel and Sephadex LH-20 yielding eight 
glycosides (1-8). All isolated compounds were in monodesmosidic 
form possessing the same sugar moiety, -glucose. Furthermore, 
compounds 1-4 were isoflavonoid glycosides with different 
substitution patterns on the A and B rings (Figure 1). 
 
The HR-MS spectra of 1 showed major ion peaks in the positive 
and negative modes at m/z 463.1278 [M+H]+ and 497.0490 [M+Cl]-  
respectively in accordance with the molecular formula C22H22O11. The NMR data of 1 were consistent with the presence of an 
isoflavonoid type glycoside with a glucose moiety at C-7 position. 
All NMR data presented in Table 1 were superimposable with   
those reported by Vitor et al. [7]; therefore, the structure of 1      
was identified as 5,5’-dihydroxy-3’-methoxy-isoflavone-7-O--D-
glucopyranoside. 
 
The MS spectrum of 2 (m/z 467.0409 [M+Cl]-) revealed the 
molecular formula C21H20O10, 30 amu less than 1 implying loss of a methoxy group (C21H20O10). A glycosidation with same sugar residue at C-7 was evident from the NMR data (Table 1), 
superimposable with those reported for 1 [7]. Thus, compound 2 
was established as genistin. In a similar fashion by using MS 
analyses and 1D NMR data, structures of compounds 3 and 4 were 
determined as sissotrin [7] and 5,4’-dimethoxy-isoflavone-7-O--D-
glucopyranoside [8]. The molecular formula of 5 was determined as 
C26H32O11 based on the MS analyses (m/z 555.1200, [M+Cl]-). A comparison of 5’s NMR data (Table 1) with those reported by 
Machida et al. [9] led to the identification of 5 as (7S,8R)-5-
methoxydehydro-diconiferyl alcohol-4-O--D-glucopyranoside. The 
NMR data of 6 (Table 1) were superimposable with those reported 
for 4-O-lariciresinol-glucoside [10]. The structure of 7 was readily 
deduced from the NMR data as 2-phenylethyl--D-glucopyranoside, 
a simple phenyl ethanoyl glycoside [11a,b]. All compounds (1-7) 
are reported for the first time from Astragalus taxa. Additionally, a 
phytosterol (8) was isolated from CH2Cl2 extract and identified as -Sitosterol-3-O--D-glucopyranoside, a common metabolite 
encountered in plant kingdom, based on NMR data in comparison 
with those reported in the literature [12a,b]. 
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Figure 1: Formula of compounds 1-8 
 
Table 1: 13C-NMR data for compounds 1-7 (150 MHz, DMSO-d6). 
 
 1 2 3 4 5 6 7 
1 - - - -  135.8 135.1 69.9 
2 155.2 154.9 155.5 154.8 115.8 113.2 36.1 
3 122.9 122.7 122.9 122.3 149.7 149.2 139.2 
4 180.9 180.8 181.1 180.3 118.4 145.9 129.4 
5 162.1 162.0 163.8 164.9 144.2 115.9 128.7 
6 100.1 100.1 100.3 99.5 118.5 118.2 126.5 
7 163.4 162.9 162.3 162.7 87.3 82.1 128.7 
8 95.1 95.0 96.3 94.4 53.7 52.9 129.4 
9 157.6 157.6 157.8 157.1 62.1 59.1 - 
10 106.6 106.6 106.8 106.1 - - - 
1 123.6 123.5 123.4 122.6 131.1 138.1 - 
2 116.8 130.6 130.8 136.7 110.8 115.5 - 
3 148.2 115.6 114.5 113.7 146.7 147.9 - 
4 112.5 155.4 159.9 159.2 147.5 145.1 - 
5 146.6 115.3 114.5 113.7 129.7 121.1 - 
6 120.4 130.6 130.8 136.7 115.4 132.1 - 
7 - - - - 133.7 32.6 - 
8 - - - - 128.6 42.4 - 
9 - - - - 63.4 72.4 - 
OCH3 56.2 - 55.8 55.2 56.2 56.1 - OCH3 - - - 57.8 56.2 56.2 - 
1 100.4 100.4 100.6 99.2 100.5 100.6 103.3 
2 73.5 73.6 73.8 73.8 73.7 73.7 73.9 
3 76.8 76.9 77.3 76.1 77.3 77.3 77.2 
4 70.8 70.1 70.3 70.0 70.1 70.2 70.6 
5 77.6 77.7 77.9 76.2 77.5 77.5 77.4 
6 61.1 61.1 61.3 64.0 61.2 61.2 61.6 
 
  
Compounds 1−7 were evaluated for their cytotoxic activity against 
three cancer cell lines (PC3, HT-29 and MDA-MB-231) and             
a transformed cell line (HEK 293) using the MTT method.  None of 
the isolates displayed cytotoxicity toward the prostate cancer cell 
line PC-3. The isoflavone metabolites (1-4) and the 
dehydrodiconiferyl alcohol derivative (5) exhibited modest 
cytotoxicity against HT-29 and MDA-MB-231 with IC50 values 
ranging from 29.76 to 73.01 M. Against the colon carcinoma    
HT-29, the activity of 4-O-lariciresinol-glucoside (6) with an IC50 
value of 2.69 M was noteworthy. Lariciresinol and its derivatives 
were shown to be cytotoxic agents against a series of cancer cell 
lines, viz. P-388, SK- MEL 2, SGC-7901 and SMMC-7721 
[13a,b,c]. 4-O-lariciresinol-glucoside’s cytotoxicity was reported by 
Kim et al. against the melanoma cell line SK-MEL 2 (IC50 = 13.46 
M), whereas the compound was found to be inactive versus   
HCT-15, a colon carcinoma cell line (IC50  = >30 M) [13c].  
Cytotoxicity of lignans can be associated with different mechanisms 
such as topoisomerase II inhibition, anti-tubulin, oestregonic and 
anti-angiogenic effects. Since compound 6 exhibits a selective and 
potent cytotoxicity compared to the positive control doxorubicin, 
further studies are warranted to investigate its toxicity against 
different cancer cell lines as well as its mechanism of action. 
 
Saponins, polysaccharides and flavonoids, are the principle active 
constituents of Astragalus [14]. It also includes components such as  
Table 2: IC50 values (μM) of A. lycius compounds (1-7) and doxorubicin as positive 
control. 
 
β-sitosterol, anthraquinones, alkaloids, amino acids and metallic 
elements. 
 
Consequently, as part of our ongoing works on the Turkish 
Astragalus species, we investigated the glycosidic contents of        
A. lycius. We have shown that A. lycius, which belongs to Section 
Onobrychium, contains only phenolic and flavonoid type 
glycosides. Based on earlier phytochemical studies, 31 out of 447 
Turkish Astragalus species, from 17 different sections, have been 
investigated for their secondary metabolite contents. Most of the 
studied sections, namely Sect. Pterophorus (A. brachypterus [15a], 
A. baibutensis [15b], A. trojanus [15c], A. ptilodes var. cariensis 
[15d], A. wiedemannianus [15e], A. tmoleus var. tmoleus [15f]), 
Sect. Rhacophorus (A. microcephalus [16a], A. zahlbruckneri  
[16b], A. cephalotes var. brevicalyx [16c], A. amblolepis [16d],      
A. pycnocephalus var. pycnocephalus [16e], A. erinaceus [16f], A. 
prusianus [16g], A. schottianus [16h] and A. plumosus [6a]),     
Sect. Macrophyllium (A. oleifolius [17a]), Sect. Proselius              
(A. campylosema ssp. campylosema [17b], A. elongates [17c]), Sect. 
Stereocalyx (A. stereocalyx [17d]), Sect. Christiana (A. gilvus [17e] 
and A. melanophrurius [3]), Sect. Halicacabus (A. halicacabus 
[17f]), Sect. Hypoglottis (A. cicer [15d]) and Sect. Adiaspastus (A. 
aureus [18]), provided cycloartane glycosides, whereas cycloartane 
and oleanane type saponins were encountered together in a few 
sections, Sect. Chronopus (A. hareftae [6b] and A. icmadophilus 
[6c]), Sect. Melanocercis (A. angustifolius [19a]), Sect. Eustales   
(A. flavescens [19b]) and just one species of Sect. Rhacophorus    
(A. pycnocephalus [16e]). The sect. Malacothrix (A. tauricolus [20] 
were provided oleanane type saponins wholly. 
 
A phytochemical study on A. lycius from Sect. Onobrychium 
resulted in the isolation of eight secondary metabolites. 
Interestingly, no cycloartane or oleanane type triterpene glycoside, 
the main constituents of Astragalus spp., was isolated. This peculiar 
feature characterizes a very limited group of Astragalus spp. such as 
Sect. Hymenostegis (A. lagurus [21a]) and Sect. Vulneraria (A. 
vulneraria [21b]; A. onobrychis [21c]).  
 
Our results clearly indicate that the presence of cycloartane type 
saponins is not the case for all Astragalus spp. Since A. lycius is 
Compound  IC50 (μM) 
 PC-3 HT-29 MDA-MB-231 HEK 293 
1 >100 29.76 ± 2.5 35.37 ± 1.6 >100 
2 86.13 ± 3.9 55.30 ± 1.8 46.82 ± 3.1 >100 
3 >100 47.24 ± 1.9 >100 >100 
4 >100 41.28 ± 1.7 73.01 ± 3.8 60.85 ± 2.3 
5 >100 39.07 ± 1.7 88.12 ± 4.9 >100 
6 >100 2.69 ± 0.2 >100 >100 
7 >100 97.29 ± 2.1 >100 >100 
Doxorubicin 9.16 ± 0.8 7.35 ± 0.9 11.08 ± 1.4 1.58 ± 0.3 
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only phytochemically studied species of the Sect. Onobrychis 
including 31 species, it is not rational to place the section amongst 
cycloartane deficient members of the genus. Further studies are 
warranted for the Sect. Onobrychis to clarify its chemotaxonomic 
significance in the genus Astragalus. 
 
Experimental 
 
Plant Material: A. lycius Boiss. was collected from Cevizli Village, 
Muradiye from altitude of 1754 m, Van, East Anatolia, Turkey in  
June 2010. Samples of the plant material were identified by Fevzi. 
Özgökçe (Yüzüncü Yıl University, Faculty of Science & Art, 
Department of Biology, Van, Turkey). Voucher specimen has been 
deposited in the Herbarium of Yüzüncü Yıl University, Van, 
Turkey (F 13 739). 
 
Extraction and Isolation: Air-dried and powdered plant material of 
A. lycius (whole plant; 655 g) was first extracted with n-hexane (1 x 
4 L) under reflux at 68 ºC and then with MeOH (3 x 4 L) under 
reflux at 64 ºC for 6 hours (each). After filtration and evaporation 
procedures, n-hexane (2.9 g) and MeOH (55.75 g) extracts were 
obtained. The MeOH extract (55.75 g) was dissolved in water (500 
mL) and partitioned with n-hexane (3 x 250 mL), CH2Cl2 (3 x 250 ml) and n-BuOH (4 x 250 mL), respectively, then n-BuOH phase 
(9.2 g) subjected to vacuum liquid chromatography (VLC), using 
reverse-phase material (Lichroprep RP-18, 25-40 mm, 130 g). 
Elution was performed with water (750 mL), H2O:MeOH (7:3, 1350 mL; 5:5, 1350 mL; 4:6, 1050 mL) and MeOH (1050 mL) to 
afford 3 main fractions (Fr.1-3). Main fraction (Fr.1, 4.85 g) was 
subjected to open column chromatography by using Sephadex    
LH-20, eluted with MeOH to give 2 sub-fractions (Fr.1.A, Fr.1.B). 
The sub-fraction Fr.1.A (2.35 g) was chromatographed on medium 
pressure liquid chromatography (MPLC) by using RP-18 as an 
adsorbent with the solvent system H2O:MeOH (9:1), which was increased step wise to H2O:MeOH (6:4) to give 3 sub-fractions. The sub-fraction Fr.1A.1 (274 mg) was applied to Sephadex LH-20, 
eluted with MeOH to give a sub-fraction (Fr.1.A.1.1, 25 mg) that 
was further applied to Si gel (Merck. 7734, 18 g) column 
chromatography. Elution was carried out under isocratic condition 
with CH2Cl2:MeOH (95:5) to give 7 (3.3 mg). The sub-fraction Fr.1.A.2 (300 mg) was applied to Sephadex LH-20, eluted with 
MeOH to give a sub-fraction (Fr1.A.2.1, 90 mg) that was further 
applied to Si gel (Merck. 7734, 32 g) column chromatography. 
Elution was carried out with solvent system CH2Cl2:MeOH (96:4) to give 6 (9 mg) and 5 (4.6 mg). Fr.1.A.3 (210 mg) was subjected to 
open column chromatography by using Sephadex LH-20, eluted 
with MeOH to give 2 (6.3 mg). The sub-fraction Fr.1.B (650 mg) 
was subjected to Si gel (Merck. 7734, 80 g) open column 
chromatography, developed with CH2Cl2:MeOH:H2O (90:10:1) to afford 1 (50 mg).  
 
The CH2Cl2 phase (5.5 g) was subjected to Si gel column chromatography, eluting with CH2Cl2:MeOH (95:5) to give four main fractions (Fr.A-Fr.D). The main fraction (Fr.A; 280 mg) was 
precipitated using MeOH. The precipitate (180 mg) was subjected 
to Si gel column chromatography. Elution was carried out with 
CH2Cl2: MeOH (95:5) yielding 8 (60 mg). The same method was applied to the main fraction (Fr.B; 170 mg) that precipitated using 
MeOH. The obtained precipitate (72 mg) was subjected to Si gel 
column chromatography with solvent system CH2Cl2:MeOH (95:5) to give 4 (17 mg). The main fraction (Fr.C; 400 mg) was applied to 
Si gel column chromatography with solvent system CH2Cl2:MeOH (95:5) to give 3 (45 mg). 
 
Cell Culture and in vitro Cytotoxicity Assay: Cytotoxicity of A. 
lycius compounds were determined using the general procedure 
based on cell viability with a modified MTT [3-(4,5-Dimethyl-2-
thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide)] assay [22], which 
measures the activity of mitochondrial reductase of viable cells 
colorimetrically. The test was carried out with three cancerogenic 
cell lines [PC3 (human prostate carcinoma), (ATCC catalog no: 
CRL-1435TM)], [HT-29 (human colon carcinoma) (ATCC catalog 
no: HTB-38TM)], [MDA-MB-231 (human breast carcinoma) 
(ATCC catalog no: HTB-26TM)] and a transformed cell line [HEK 
293 (Human Embryonic Kidney 293) (ATCC catalog no: CRL-
1573TM)]. 
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